Arbutus Biopharma | 10-Q: Quarterly report
May 2 16:40 ET
Arbutus Biopharma | 8-K: Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 2 07:33 ET
Arbutus Biopharma | 8-K: Current report
May 2 07:28 ET
Arbutus Biopharma | DEF 14A: Definitive information statements
Apr 10 16:09 ET
Arbutus Biopharma | DEFA14A: Others
Apr 10 16:09 ET
Arbutus Biopharma | 8-K: Current report
Apr 4 08:35 ET
Arbutus Biopharma | 10-K: Annual report
Mar 5 16:54 ET
Arbutus Biopharma | 8-K: Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Feb 29 07:33 ET
Arbutus Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Whitefort Capital Management, LP(7.9%),David Salanic(7.9%), etc.
Feb 14 16:46 ET
Arbutus Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Two Seas Capital LP(5.4%),Two Seas Capital GP LLC(5.4%), etc.
Feb 14 10:52 ET
Arbutus Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.2%)
Feb 12 09:44 ET
Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Naftzger J. Christopher
Feb 5 19:59 ET
Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sims Karen
Feb 5 19:59 ET
Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer HASTINGS DAVID C
Feb 5 19:59 ET
Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sofia Michael J.
Feb 5 19:58 ET
Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer McElhaugh Michael J.
Feb 5 19:58 ET
Arbutus Biopharma | 8-K: Current report
Jan 8 00:00 ET
Arbutus Biopharma | 8-K: Current report
Jan 4 00:00 ET
Arbutus Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Two Seas Capital LP(5.7%),Two Seas Capital GP LLC(5.7%), etc.
Nov 21, 2023 08:00 ET
Arbutus Biopharma | 8-K: Current report
Nov 9, 2023 16:02 ET
No Data
No Data